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Small heat shock protein alteration provides a mechanism
to reduce mesangial cell contractility in diabetes and
oxidative stress
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Alteration to small heat shock proteins provides a mechanism and activation of protein kinase cascades, suggest that
to reduce mesangial cell contractility. early in the course of diabetes, multiple pathways may
Background. Small heat shock proteins are expressed in converge to increase reactive oxygen species and a diabe-many tissues and are proposed to regulate actin filament dy-
tes-induced oxidative stress [1]. This may arise from thenamics when dissociated into small aggregates and phosphory-
increased generation of free radicals that accompanieslated in a p38 mitogen-activated protein kinase (p38MAPK)-
dependent manner. glucose autoxidation and the process of oxidative glycox-
Methods. p38MAPK activity and small heat shock protein- idation [2] or the condition of “pseudohypoxia,” in which
25 (Hsp25) were determined in glomeruli from rats with experi- superoxide radicals are formed in the mitochondrial re-mental diabetes induced by streptozotocin administration and
sponse to the altered reduced pyridine nucleotide ratiosin isolated glomeruli exposed to a free radical stress. Contrac-
that follow glucose metabolism through the polyol path-tile responsiveness of mesangial cells was determined by the
serum-induced contraction of cell-embedded type I collagen way [3]. A major challenge in the investigation of the
gels. microvascular complications of diabetes has been to
Results. In experimental diabetes, there is an activation of
identify which of many hyperglycemia-driven biochemi-p38MAPK, a decrease in the size of Hsp25 molecular aggre-
cal changes contribute to microvascular dysfunction.gates, from large to small homo-oligomers, and an increase in
the phosphorylation of Hsp25. In control glomeruli, a free Stress proteins/heat shock proteins are highly conserved,
radical stress, H2O2, activated p38MAPK and increased Hsp25 abundantly expressed proteins that act as molecular
in a concentration-dependent manner. Additionally, H2O2 de- chaperones in many conditions of cellular stress, includ-
creased the contractility of cultured mesangial cells concomi-
ing heat shock [4]. An increase in one group, small heattant with an increase in Hsp25 phosphorylation and a reduction
shock proteins (small Hsp, murine/rodent 25 kd, humanin Hsp25 aggregate size. These effects were significantly re-
duced by SB202190, an imidazole-derivative cell-permeable 27 kd), is proposed to confer tolerance to a number of
inhibitor of p38MAPK. stressors in addition to the stress of heat shock [5]. Under
Conclusions. It has been proposed that the generation of diabetic conditions, there is a loss of glomerular mesan-oxygen-derived free radicals in diabetes may be linked causally
gial cell contractility with alteration in the actin cytoskel-to a loss of glomerular contractile reactivity and thus hyperfil-
eton [6]. We have investigated conditions under whichtration in the early stages of diabetes mellitus. This study pro-
vides a mechanism for alteration of mesangial cell contractile mesangial cell contractile response may be defective, and
responsiveness through phosphorylation of Hsp25 and may be in this study, we describe a possible mechanism involving
a mechanism underlying abnormalities in glomerular hemody- phosphorylation of small heat shock proteins. Heatnamics in diabetes and in the presence of free radical stress.
shock proteins are expressed in many tissues, and in-
creased expression of small Hsps enhances the survival
of cells exposed to oxidant stress [7]. Protection may beSeveral lines of evidence, including the activation of
conferred by two properties of the small Hsps. Whentranscription factors, overexpression of growth factors,
present as large, unphosphorylated aggregates, Hsp27
controls intracellular reactive oxygen species and cellular
glutathione (GSH) content in Hsp27-transfected cellsKey words: p38 MAPK, mitogen activated protein kinase, glomerulus,
contractile responsiveness, diabetes, oxidative stress. [8]. In addition, when dissociated from large to small
aggregates and phosphorylated in a p38 mitogen-acti-Received for publication April 1, 1999
vated protein kinase (p38MAPK)-dependent mannerand in revised form August 12, 1999
Accepted for publication August 24, 1999 following exposure to stress, small Hsps are proposed
to regulate actin filament dynamics and to stabilize mi-Ó 2000 by the International Society of Nephrology
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crofilaments [9–12]. It has been proposed that during 0.5 mmol/L (control), 17.7 6 0.6 mmol/L (STZ diabetic),
and 9.6 6 0.7 mmol/L (STZ diabetic 1 insulin). Fromstress, this serine phosphorylation-induced conforma-
tional change in small aggregates (homo-oligomers) of each control and treatment group, four animals were
chosen at random for individual glomerular prepara-Hsp regulates the activity of this protein as an actin-
binding protein, preventing actin depolymerization and tions. Body weights and kidney weight of these animals
were documented (Table 1). Kidneys from the remainingproviding stress fibers as an adaptive response to the
stress condition [10, 13]. Small Hsp phosphorylation has animals in the control and the untreated STZ-diabetic
groups were pooled to provide a bulk glomerular prepa-been described in cardiac myocytes exposed to an oxida-
tive stress [11]. In cardiac and skeletal muscle, small Hsps ration.
Glomeruli were prepared from control, STZ diabetic,colocalize with the actin filaments of the sarcomere
I-bands and M-lines [14], but a functional significance and insulin-treated diabetic rats by differential sieving of
kidney cortex. Approximately 10,000 to 15,000 glomeruliof this has not been established beyond the proposal
that this may play a role in the assembly of the thin- were isolated from each rat kidney, with no significant
differences between treatment groups. Glomeruli werefilament array of the sarcomere and/or be involved in
contraction [5]. In the presence of raised glucose or fol- used immediately or incubated in Dulbecco’s modified
Eagle’s medium (DMEM) containing 0.5% fetal bovinelowing diabetes, isolated mesangial cells and glomeruli
show an impaired contractile response to a number of serum (FBS; vol:vol) for the indicated additions for up
to 18 hours. Mesangial cells were grown from explantedpressor agents, including arginine vasopressin [6], endo-
thelin 1 [6, 15, 16], angiotensin II [15, 17], or bradykinin glomerular cores, prepared by the digestion of intact
glomeruli from control rats with 0.5 mg/mL collagenase[18], or to KCl [19]. Activation of the MPK-activated
protein kinase MAPKAPK-2, a target for the dual tyro- type V for 10 minutes at 378C. Explanted glomerular
cores were maintained in DMEM containing 20% FBSsine/threonine-phosphorylated p38MAPK, is an ubiqui-
tously described mechanism for small Hsp phosphoryla- (vol:vol), and the resultant mesangial cells were used
at passage 3. Mesangial cells were maintained in thetion [9, 11, 20], although phosphorylation in vitro can be
by protein kinase C (PKC), specifically the d isoform previously mentioned media containing 0.5% FBS
(vol:vol) for 18 hours prior to use. When present, buthio-[21]. Our preliminary work has shown activation of
p38MAPK in the renal glomerulus in experimental dia- nine sulfoximine (BSO), a g-glutamyl cysteine synthe-
tase inhibitor, was included over this time. Prior to use,betes [abstract; Dunlop M Diabetes 47(Suppl 1):A51,
1998]. We hypothesized that p38MAPK-related phos- cells were washed rapidly with two changes of warmed
medium, and additions made for the indicated timesphorylation of small Hsps in response to glucose-induced
reactive oxygen species could alter the stability of the before cells were washed with ice-cold phosphate-buf-
fered saline (PBS) and lyzed in the buffers described inactin cytoskeleton and, subsequently, mesangial cell con-
tractility in diabetes. The aim of this study was to deter- the next section of this article.
mine the level and aggregate size of heat shock protein-
Immunoprecipitation and Western immunoblotting25 (Hsp25) in the glomerulus and in cultured mesangial
cells and to relate this to glomerular and mesangial cell For immunoprecipitation and Western immunoblot-
ting, lysates were prepared from freshly isolated glomer-contractility.
uli or cultured mesangial cells in a buffer, pH 7.5, con-
taining 150 mmol/L NaCl, 5 mmol/L Tris, 2 mmol/L
METHODS
egtazic acid (EGTA), 1 mmol/L sodium vanadate, 40
Induction of diabetes and preparation of glomeruli mmol/L sodium fluoride, 50 mmol/L b-glycerophos-
and cultured mesangial cells phate, 1% Triton X-100, 0.25% deoxycholate, 0.15
U/mL aprotinin, 10 mU/mL leupeptin, and 1 mmol/LPreparation of diabetic animals, isolation of glomeruli,
and culture of mesangial cells from explanted glomeruli phenylmethylsulfonyl fluoride. Hsp25 was immunopre-
cipitated from lysates, equalized for protein content, bywere performed as described previously [22, 23]. Briefly,
diabetes was induced in male Sprague Dawley rats incubation overnight at 48C with antibody SPA-801, a
rabbit polyclonal antibody raised against recombinant(weighing approximately 200 g) by a single intraperito-
neal injection of streptozotocin (STZ). Diabetes was mouse Hsp25, followed by a 45-minute incubation with
protein A sepharose. After washing the immunopre-maintained for three weeks before the commencement
of experiments. In each of four experimental cohorts, cipitates in PBS containing 0.2% Triton X-100, immuno-
precipitated proteins were removed from protein Aone group of diabetic animals received twice daily subcu-
taneous injections of Ultratard insulin to give a total of sepharose by boiling and resolved by sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE;25 IU/kg/day. These cohorts have been characterized
previously [23]. Over four cohorts with nine animals in 10% wt/vol acrylamide). Proteins were transferred to
polyvinylidene difluoride (PVDF) membranes in Towbineach treatment group, blood glucose levels were 6.0 6
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Table 1. Body weight and kidney weight determinations
Treatment group Control Insulin-treated diabetic Untreated diabetic
Body weight g 322.863.1 334.064.1 276.065.6a
Kidney weight g 1.6260.03 1.6760.04 2.0860.05a
Body and kidney weights were measured at sacrifice. Results are expressed as mean 6 sem for 16 animals in each treatment group (4 animals in each treatment
group over 4 separate cohorts).
a Significant difference from control and insulin-treated diabetic group
buffer (25 mmol/L Tris, pH 8.3, 192 mmol/L glycine, viously been coated with 0.2 mL of 0.67% agarose and
allowed to gel for one hour at 378C in an atmosphere of20% methanol) in the absence of SDS, probed with SPA
801 antibody, and detected by enhanced chemilumines- 5% CO2 in air. Serum-free DMEM (0.5 mL) was placed
over the gels at this time, and incubation was continuedcence (ECL). For Western immunoblotting of phospho-
p38MAPK and p38MAPK, proteins were separated by for 24 hours. Additions were made in this serum-free
medium at 23 the final concentration. After 24 hours,SDS-PAGE as described earlier in this article, trans-
ferred to PVDF membranes and probed sequentially the medium was removed and replaced with DMEM
containing any previous additions and 3% FBS. The gelwith phospho-specific p38MAPK antibody (#9211S) and
p38MAPK antibody (#9212) and detected by ECL. Phos- contraction that occurred over the subsequent six hours
was monitored by inspection, and at six hours, the float-pho- and nonphospho-p38MAPK cell extracts (#9213)
from C-6 glioma cells were included as controls. ing gel was removed intact to an acetate sheet for the
determination of the planar surface area. This method
Sizing of Hsp25 molecular aggregates is based on an extensively investigated procedure and
documented previously by Ailenberg et al [24] and Zent,Lysates for gel filtration were prepared in a buffer,
pH 7.4, containing 20 mmol/L NaCl, 20 mmol/L Tris, 5 Ailenberg, and Silverman [25].
mmol/L MgCl2, 0.1 mmol/L ethylenediaminetetraacetic
Contraction of isolated glomeruliacid (EDTA), 0.1% Triton X-100, and 50 mmol/L
b-glycerophosphate and separated for size on a 60 cm To determine glomerular contractile responsiveness,
isolated glomeruli were maintained in DMEM con-column of Sephacryl S300. The column being eluted with
lysis buffer with Triton X-100 was omitted. Fractions taining 0.5% FBS for four hours at 378C in an atmosphere
of 5% CO2 in air. When present, H2O2 and SB202190from these columns were separated by SDS-PAGE (re-
ducing conditions) followed by Western blotting (anti- were included over this time. Glomeruli were washed
rapidly in three changes of warmed medium and placedbody SPA 801) and ECL detection.
in six-well culture plates and incubated in the basal state
Glomerular and mesangial cell [32P] labeling or with the addition of KCl (50 mmol/L for 10 min) or
of Hsp25 bradykinin (100 nmol/L for 10 min). Over this time,
glomeruli were viewed with a Nikon Diaphot microscopeFor glomerular 32P labeling, glomeruli were main-
tained in DMEM containing 0.5% FBS with [32P]ortho- with an attached photographic system (FX35DX, HFX-
IIA), and nine fields were photographed over the lastphosphate (2.0 mCi/mL) for four hours. Mesangial cells
were maintained in 100 mm dishes under the same low 90 seconds of incubation. Glomerular planar surface area
was calculated from measurement of glomerular diame-serum conditions with [32P]orthophosphate (0.1 mCi/mL)
for 24 hours. When present, BSO was included in the ter, determined from an average value of four diameters
per glomerulus, measured on projected slide images us-labeling period. After this time, glomeruli and mesangial
cells were washed rapidly with three changes of warmed ing a superimposed micron scale. All intact glomeruli
within the nine photographic fields (50 to 65 glomerulimedium, and additions were made for the times indi-
cated. Lysates were prepared for immunoprecipitation, in each of two independent glomerular preparations)
were measured for each condition.SDS-PAGE, and transfer to PVDF membranes for auto-
radiography before immunoblotting by the methods de-
Determination of protein oxidationscribed earlier in this article using antibody to Hsp25
(SPA-801). As a measure of free-radical oxidation, the carbonyl
content of glomerular protein was determined. This well-
Contraction of mesangial cell-embedded collagen gels described spectrophotometric assay measures protein-
bound 2,4-dinotrophenylhydrazone formed by reactionTo determine gel contraction, mesangial cells (2.5 3
105 cells/mL) were suspended in a solution of DMEM of protein dicarbonyls with 2,4-dinitrophenyhydrazine
(DNPH) [26, 27]. Briefly, lysates were prepared fromand type I rat-tail collagen (3 mg/mL) and 0.5 mL was
placed in 24-well tissue culture dishes, which had pre- control and diabetic glomeruli as described for West-
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ern immunoblotting (mentioned previously) and were
treated for 15 minutes with 1% streptomycin sulfate to
remove contaminating nucleic acid. Lysates containing
500 to 600 mg protein were incubated with 0.2% DNPH
in 2 N HCl for one hour at room temperature in the
dark. Blank incubations were performed in the presence
of 2 N HCl alone. Proteins (derivatized or blank) were
precipitated by addition of trichloracetic acid (final con-
centration 10%) and centrifuged at 11,000 g for five
minutes. The resulting pellet was washed three times by
the addition of ethanol:ethyl acetate 1:1, vol:vol) with
vortexing followed by centrifugation after each addition.
The resulting washed protein pellet was resuspended in
6 mol/L guanidine-HCl, and the absorbence was mea-
sured at 370 nm. Carbonyl content was calculated as
nmol carbonyl per mg protein using the molar absorptiv-
ity of carbonyl-reacted DNP-hydrozone, 22,000 mol21 ·
cm21.
Reagents
Ultratard insulin was from Novo Nordisk A/S (Copen-
hagen, Denmark). STZ, collagenase Type V, buthionine
sulfoximine, b-glycerophosphate, leupeptin, phenylmeth-
ylsulfonyl fluoride, Sephacryl S-300-HR, streptomycin sul-
fate, and 2,4-dinitrophenylhydrazine were obtained from
Sigma Chemical Co. (St. Louis, MO, USA). DMEM was
from Trace Biosciences Pty. Ltd. (Castle Hill, New South
Wales, Australia). FBS was from Commonwealth Serum
Laboratories (Parkville, Victoria, Australia). [32P]ortho-
phosphate was from Bresatec (Adelaide, South Australia).
SB202190, [4-(4-Fluophenyl)-2-(4-hydroxyphenyl)-5-
5(4-pyridyl)1H-imidazole] was obtained from Calbio-
chem-Novabiochem Pty. Ltd. (Alexandria, New South
Wales, Australia). Anti-Hsp25 antibody (SPA-801) was
from StressGen Biotechnologies Corp. (Victoria, BC, Fig. 1. Detection of p38 mitogen-activated protein kinase (MAPK)
and activation in experimental diabetes. Glomeruli were isolated byCanada). Polyclonal phospho-specific p38MAPK anti-
differential sieving from the renal cortex of control Sprague-Dawleybody (#9211S), p38MAPK antibody (#9212), and phos-
rats (C) or from rats with experimental diabetes induced by an injection
pho- and nonphospho-p38MAPK cell extracts (#9213) of streptozotocin and treated with insulin injected subcutaneously twice
daily (total 25IU/kg/day) to maintain normoglycemia (STZ-D 1 insulin)were from New England Biolabs, Inc. (Beverley, MA,
or untreated (STZ-D) for four weeks. Glomeruli were rapidly lyzed,USA). Chemiluminescence reagent was from NEN Life
and an equal quantity of lysate protein was Western immunoblottedSciences Products Inc. (Boston, MA, USA). Rat tail col- (IB) antiphospho(Thr 180, Tyr182) p38MAPK antibody (A). Immu-
lagen was from Boehringer Mannheim GmbH (Mann- noblots were reprobed with a p38MAPK antibody (B). Standard phos-
pho-p38MAPK and p38MAPK protein prepared from C6 glioma cellsheim, Germany). Bradykinin was from Auspep Pty. Ltd.
was included to demonstrate specificity of the immunoblotting antibod-(Parkville, Victoria, Australia). ies. Control glomerular lysates were similarly prepared after an 18-hour
incubation at a raised glucose level. After densitometry, p38MAPK
Statistics activation was quantitated as phospho-p38MAPK/p38MAPK ratio and
expressed as a percentage of control for each experimental cohort. TheSingle comparison analysis was by Student’s unpaired
immunoblots shown are from representative animals within a singlet-test (two-tailed). Where multiple comparisons were treatment cohort. Values for p38MAPK activation in each cohort were
made, significance was determined by analysis of vari- combined to give a single value for each treatment, and the results are
expressed as mean 6 sem for N 5 4 cohorts. Statistically significantance in conjunction with Fisher’s least-squares differ-
differences over four separate treatment cohorts or in four independentence, and significance was assumed at P , 0.05.
glomerular preparations incubated over 18 hours are shown as *P , 0.05.
RESULTS
Detection of p38MAPK in glomerular extracts
The level of p38MAPK protein and activated phos-
pho-p38MAPK was determined by Western immu-
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noblotting in animals from four separate treatment co-
horts. Over these cohorts, the level of p38MAPK was
unchanged. A representative immunoblot of p38MAPK
present in lysates of glomeruli rapidly isolated from con-
trol, insulin-treated diabetic, and diabetic animals is
shown in Figure 1. When p38MAPK activation was
determined as the ratio of phospho-p38MAPK to
p38MAPK and expressed as percentage of control, there
was a significant increase in p38MAPK activation (to
242 6 25% of control, P , 0.05). When compared with
control, there was no alteration in the activation of
p38MAPK in insulin-treated diabetic animals. An activa-
tion of p38MAPK could be shown in control glomeruli
exposed to raised glucose levels over 18 hours in culture.
Detection of Hsp25 in
glomerular extracts
In isolated untreated diabetic glomeruli, there was a
fourfold increase (4.31 6 0.53-fold, P , 0.01, N 5 4
cohorts) in the abundance of Hsp25. Western immu-
noblotting (Fig. 2) shows the presence of Hsp25 and
some further, as yet uncharacterized, immunoreactive
proteins that appear to be differentially regulated by
the diabetic condition. Over four separate experimental
cohorts, Hsp25 was significantly reduced following the in
vivo treatment of diabetic animals with insulin to restore
normoglycemia. In nondiabetic (control) glomeruli, an
increase in Hsp25 was seen under conditions of oxidative
stress induced by increasing concentrations of H2O2
(Fig. 3). This increase occurred over one hour concomi-
tant with an increase in the activation of p38MAPK.
Activation of p38MAPK in treated mesangial cells
Phosphorylation of p38MAPK was investigated in cul-
tured mesangial cells under conditions that would inter-
fere with glutathione status, a major antioxidant defense
of the microvascular cell. The addition of BSO, a
g-glutamyl cysteine synthetase inhibitor, increased the
Fig. 2. Detection of heat shock protein 25 (Hsp25) in experimental
sensitivity of p38MAPK activation in the presence of diabetes. Lysates prepared from glomeruli isolated as described in the
Methods section and in Figure 1 were Western immunoblotted (IB)H2O2 (Fig. 4). Inclusion of BSO at H2O2 concentrations
with anti-Hsp25 rabbit polyclonal antibody. Immunoblots were re-100 mmol/L and 200 mmol/L, where minimal p38MAPK
probed with an anti Stat-3 antibody (shown to be a constitutively acti-
activation is seen in the presence of H2O2 alone, signifi- vated protein in this glomerular preparation) and after densitometry
Hsp25 was quantitated as Hsp25/Stat3 ratio. The immunoblots showncantly increased p38MAPK activation (2.18- and 2.05-
are from representative animals in a single treatment cohort. The statis-fold, respectively).
tically significant differences following quantitation of Hsp25/Stat3 ratio
over four separate treatment cohorts are expressed as mean 6 sem and
Phosphorylation of Hsp25 and size of Hsp25 are shown as **P , 0.005 and *P , 0.01.
molecular aggregates in treated mesangial cells
The phosphorylation of Hsp25, immunoprecipitated
from cultured mesangial cells, was investigated. In cells
metabolically labeled with [32P], Hsp25 phosphorylation where the control 5 1. The relative phosphorylation of
Hsp25 was significantly increased in H2O2-treated mesan-was increased in cells treated with H2O2 (Fig. 5). For two
independent experiments, the relative phosphorylation gial cells (5.6-fold). There was no increase in the relative
phosphorylation of Hsp25 in cells treated with SB202190,was calculated as [32P]Hsp25 (arbitrary densitometric
units after autoradiography) relative to Hsp25 Western an imidazole derivative cell-permeable inhibitor of
p38MAPK activity. In mesangial cells treated concur-immunoblot (arbitrary densitometric units after ECL),
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Fig. 3. p38MAPK phosphorylation and detection of Hsp25 in isolated
glomeruli following H2O2 addition. Glomeruli were treated for one hour
with H2O2 at the indicated concentrations, lyzed, and immunoblotted
(IB) with antiphospho(Thr 180, Tyr182)p38MAPK antibody (upper
panel) or anti-Hsp25 antibody (lower panel). This shows a representa-
tive immunoblot of two independent experiments with essentially simi-
lar findings. Fig. 4. p38MAPK phosphorylation in response to H2O2 following BSO
pretreatment of cultured mesangial cells. Mesangial cells were cultured
with BSO for 18 hours and exposed to H2O2 at the indicated concentra-
tions for 1 hour before lysates were prepared for immunoblotting (IB)
with antiphospho(Thr 180, Tyr 182)p38MAPK antibody and p38MAPK
antibody. This shows a representative immunoblot of three independent
rently with H2O2 and SB202198, relative phosphorylation experiments with essentially similar findings.
was reduced compared with H2O2 alone (2.6- vs. 5.6-fold,
representative data not shown). The addition of BSO
alone was without effect on Hsp25 relative phosphoryla-
tion. When Sephacryl S300 gel filtration was used to
although this shift in apparent molecular size distributionseparate Hsp25 in the molecular weight range of .443
profile was a consistent finding, the difference in appar-to 21 kd, and Hsp25 subsequently immunolocalized by
ent molecular size distribution was less marked in theWestern blotting after SDS-PAGE under reducing con-
isolated glomeruli than the shifts seen in mesangial cellsditions, it was shown that BSO and H2O2 reduced the
treated in vitro. The relative phosphorylation of Hsp25apparent size of Hsp25 to smaller aggregates than seen
was determined in glomeruli treated for four hours exin untreated cells (Fig. 6A). Under all conditions, the
vivo with [32P]orthophosphate. This labeling time wasinhibitor of p38MAPK activity sustained large molecular
shown to be sufficient to provide a pool of 32P-ATP formass aggregates in these cells (SB202190 alone; Fig. 6A).
phosphorylation (results not shown). Relative phosphor-
Phosphorylation of Hsp25 and size of Hsp25 ylation of Hsp25, immunoprecipitated from glomerular
molecular aggregates in glomeruli in lysates, was significantly increased in the untreated dia-
experimental diabetes betic condition when compared with control (1.48 6
0.180-fold, N 5 5; representative autoradiograph isGlomerular lysates were prepared, and the apparent
shown in Fig. 6C).molecular mass of Hsp25 was determined in glomeruli
from nondiabetic (control) and untreated diabetic glo-
Mesangial cell contractionmeruli, rapidly isolated to reflect the in vivo condition.
Differences in the ability of mesangial cells to exert aApparent molecular mass was consistently shifted to-
contractile force within a collagen gel in response toward larger aggregate sizes in control and toward smaller
serum stimulation were seen when the planar surfaceaggregate sizes in untreated-diabetes (representative
profiles are shown in Fig. 6B). It should be noted that areas of gels were determined (Table 2). Inclusion of
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Fig. 5. Hsp25 phosphorylation in cultured glomerular mesangial cells.
Cells were metabolically labeled with 0.5 mCi [32P]orthophosphate/107
cells for 18 hours with the indicated treatments. Cells were lyzed and
immunoprecipitated (IP) with anti-Hsp25 antibody, and the 32P content
of Hsp25 was detected by autoradiography after SDS-PAGE and trans-
fer to nitrocellulose (upper panel). Subsequent immunoblotting of this
membrane with anti-Hsp25 antibody provided a determination of total
Hsp25 in the immunoprecipitate (lower panel). This shows a representa-
tive autoradiograph and immunoblot of three independent experiments
with essentially similar findings.
BSO did not have a significant effect on the surface area
of these gels, whereas H2O2 caused the gel area to be
increased significantly, which can be equated in this sys-
tem with a loss of contraction. This contractile loss was
significantly reduced by the inclusion of SB202190. Un- Fig. 6. Sizing of Hsp25 molecular aggregates in treated mesangial cells
der these conditions, SB202190 alone had a significant and in experimental diabetes. Following treatment of cultured mesan-
gial cells with BSO (18 h), SB202190 (18 h), or H2O2 (4 h), the Hsp25positive effect on contractility.
aggregates in lysates of cultured mesangial cells were separated by gel
filtration with detection of Hsp25 in the indicated column fractions by
Contractility of isolated glomeruli SDS-PAGE under reducing conditions and immunoblotting (IB) with
anti-Hsp25 antibody (A). Lysates of glomeruli were rapidly preparedThe planar surface area of glomeruli isolated from
from nondiabetic (control) or untreated diabetic animals (STZ-D) and
control and untreated diabetic animals was not signifi- were similarly isolated (B). Arrows indicate the position of molecular
mass markers apoferritin (443 kd), catalase (232 kd), bovine serumcantly different. Additionally, there was no significant
albumin (67 kd), and soybean trypsin inhibitor (21 kd). This showsdifference seen when samples of isolated glomeruli were representative profiles of three independent experiments. The phos-
incubated with SB202190 (control and untreated dia- phorylation of 32P-labeled Hsp25 immunoprecipitated from nondiabetic
(control) and untreated diabetic glomerular preparations incubated forbetic) or H2O2 (control glomeruli only). Control glomer-
four hours ex vivo with [32P]orthophosphate is shown in an autoradio-uli responded to short-term exposure to KCl with a sig- graph representative of five independent determinations (C).
nificant reduction in planar surface area, indicating
contraction of the glomerulus. No change in planar sur-
face area was seen after KCl in glomerular preparations tractile response to KCl was restored when SB202190
from untreated diabetic animals, but a significant reduc- was present over the pretreatment time (Table 3). Glo-
tion could be elicited by KCl when these glomeruli were meruli from untreated diabetic animals were also unre-
pretreated for four hours with SB20219. In a similar sponsive to bradykinin with no change in planar surface
manner, glomeruli from control animals failed to re- area seen (to 10380 6 154 mm2 after bradykinin, 100
nmol/L) compared with a significant reduction in planarspond to KCl after pretreatment with H2O2, but a con-
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Table 2. Contractility of mesangial cell-embedded type I collagen gels
Condition 1 3% FBS gel area mm2
Pre-treatment Nil 1 BSO 200 mmol/L 1 SB202190 10 mmol/L
Treatment
Nil 152610 17468 12268b
H2O2 100 lmol/L 168610 350610b 12566b
H2O2 200 lmol/L 29962a 36468b 20264b
H2O2 400 lmol/L 35469a 369612 235610b
Values for gel planar surface area are expressed as mean 6 sem for 10 independent experiments.
a Significant difference from cells without treatment
b Significant difference from the equivalent treatment condition without the indicated pretreatment
Table 3. Contractility of isolated glomeruli
Planar surface area lm2
Control Untreated diabetic
KCl KCl
Treatment group Nil 50 mmol/L Nil 50 mmol/L
Pre-treatment
Nil 94726140 81466149a 107756156 106806181
SB 202190 10 lmol/L 94656198 78156242a 101406140 94366201a
H2O2 100 lmol/L 91716250 91656298 — —
H2O2 200 lmol/L 89656247 91606194 — —
H2O2 200 lmol/L 1
SB 202190 10 lmol/L 93246171 80046172a — —
Values for glomerular planar surface area are expressed as mean 6 sem (50 to 65 glomeruli at each condition).
a Significant difference from equivalent pretreatment without KCl
Table 4. Glomerular protein carbonyl content hours, there was a significant concentration-dependent
increase in protein carbonyl content (Table 3).Control Untreated diabetic
Treatment group Carbonyl content nmol/mg protein
Pretreatment DISCUSSION
Nil 0.5160.05 1.2460.12a
In this study, the finding of an increase in small Hsp25H2O2 100 lmol/L 0.9260.10b —
H2O2 200 lmol/L 1.3460.21b — and an alteration in its oligomeric size and phosphoryla-
Values are shown as mean 6 sem for eight independent determinations at each tion may have significant implications for the diabetic
condition. condition. By analogy, with investigations in other sys-a Significant difference from control
b Significant difference from control without pretreatment tems, these findings may provide an underlying mecha-
nism for the widely described functional deficit in glo-
merular and mesangial cell contractility in early diabetes
[6, 15–18] where an oxidative stress is present. An oxida-
surface area in control glomeruli [to 8054 6 204 mm2 tive stress-induced F-actin reorganization, mediated by
after bradykinin (55 glomeruli), P , 0.005]. Compared the p38MAPK/MAPKAPK-2/small Hsp pathway, is pro-
with the planar surface area of control glomeruli without posed to create a stress-resistant state in a number of
pretreatment (Table 3), an overall reduction in planar cellular models, and to provide a protective situation in
surface area of 15% is seen in control glomeruli following which cytotoxicity and apoptosis are not an inevitable
short-term exposure to bradykinin. outcome of activation of stress-activated kinases [5]. In
a renal context, this may be a mechanism providing pro-
Protein carbonyl content to determine tection in seemingly diverse conditions of hypertonic
protein oxidation stress [28], experimental nephrotic syndrome [29], and
Carbonyl groups can be introduced into proteins by renal ischemia [30]. In each of these conditions, there
oxidative modification. Proteins from glomeruli isolated is increased expression of small Hsps and a proposed
from untreated diabetic animals contained significantly regulation of pathophysiologic cytoskeletal changes. We
more DNPH-reactive dicarbonyl groups than glomeruli propose that, paradoxically, this conferred resistance of
isolated from control animals (Table 4). Additionally, the cytoskeleton may explain a well-described early renal
diabetic condition of glomerular and mesangial cell hy-when control glomeruli were exposed to H2O2 over four
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pocontractility, a condition that contributes to a po- molecular aggregates of small Hsp to act as a chaperone
for enzymes of glutathione synthesis, thus protectingtentially damaging unregulated hyperfiltration in the
glomerulus [reviewed in 31]. Actin-containing micro- folding intermediates, as is seen for other non-native
proteins in heat shock [37], but this is not currentlyfilaments that predominate in the pericapillary exten-
sions of mesangial cells allow the cell to sense any cap- known. The alteration of small Hsp oligomeric size distri-
bution, shown in this study in diabetes, would not favorillary distending force and, by isometric contraction,
prevent further glomerular distention [32]. A reduction protection through this mechanism and could underlie
a glucose-induced reduction in glutathione in vascularin the contraction of mesangial cells has been shown in
modeled diabetic conditions [6, 15, 33] and in response and other cells [38, 39] and a loss of glutathione-depen-
dent protection from over production of reactive oxygento reactive oxygen species following puromycin amino-
nucleoside treatment [25]. The modeled system, which species. Thus, despite an increase in the abundance of
Hsp25 in experimental diabetes, a shift in the oligomericdetermines mesangial cell contraction within a collagen
matrix, requires that contractile forces are transmitted size to smaller phosphorylated forms may compromise
any protective response to oxidative stress and may con-to a matrix of dense collagen fibers via mesangial cell-
matrix attachments [24, 25]. A loss of contraction may comitantly contribute to a loss of microfilament reactiv-
ity. It has been shown that a stress-induced phosphoryla-occur by the direct disruption of actin filaments or by
the failure of actin filaments to generate the elastic force tion and disaggregation provides the only condition in
which it is possible for small Hsps to modulate the actinto achieve gel contraction. This latter effect may be ex-
pected if phosphorylated small Hsp induced stabilized microfilament response to reactive oxygen species [40].
Activation of other MAPKs, specifically p42MAPKmicrofilaments. We show that mesangial cell and glomer-
ular hypocontractility seen in the presence of H2O2 can [or extracellular signal-regulated kinase-2 (ERK-2)], has
been shown in glomeruli isolated from STZ-induced dia-be significantly alleviated and contraction restored by
addition of SB202190, an inhibitor of p38MAPK activity. betic rats and in isolated glomeruli cultured in high-
glucose conditions for five days [41]. However, Zent,Glomeruli from untreated diabetic animals are unre-
sponsive to a pressor agonist (bradykinin) and to KCl. Ailenberg, and Silverman have shown recently that in
the model of serum-induced mesangial cell contractionContractility to KCl, a receptor-independent stimulus,
was restored by inhibition of p38MAPK, supporting res- of a collagen gel, ERK-2 is tyrosine phosphorylated, but
gel contraction is independent of this ERK-2 phosphory-toration of a generalized contractile deficit. Investigation
of the effect of SB202190 was not extended to study lation and activation [42].
Protein kinase C is also activated in many tissues,the short-term response of receptor-dependent pressor
agonists. It has been shown that pressor agonists such including the glomerulus [3, 43], in diabetes and in mes-
angial cells in response to raised glucose [44]. There isas endothelin 1 [34], angiotensin II [35], and kinins [36]
can activate p38MAPK as a rapid response in cardiovas- considerable evidence for an involvement of the PKCbII
isoform, based on the efficacy of a specific inhibitor ofcular cells. We would speculate that this has the potential
to modify short-term contractile responsiveness by the PKCbII to abolish or reduce a number of microvascular,
macrovascular, and cardiac sequelae of diabetes [1, 45].same mechanism proposed for oxidative stress.
Investigations in murine NIH 3T3 cells transfected It is not known whether PKCbII contributes to the phos-
phorylation of small Hsps in diabetes, but it has beenwith wild-type human Hsp27 and with constructs con-
taining nonphosphorylatable mutants have shown that shown that, of recombinant PKC isoforms tested, the d
isoform is an effective Hsp kinase, whereas the bI, bII,serine residues 15, 78, and 82 are key to the control of
Hsp27 oligomeric structure [8]. A similar change in Hsp e, and z isoforms are poor small Hsp25/27 kinases [21].
A possible role for PKCd in small Hsp phosphorylationoligomer size has been described in murine fibrosarcoma
cells transfected with human Hsp27 or NIH 3T3 cells should be considered, but may differ between tissues.
Myocardial particulate PKCd is increased in an earlytransfected with murine Hsp25 (phosphorylated serines
15 and 86) treated with H2O2 or with BSO, where a cardiomyopathy seen in the BB/W or diabetic rat [46]
and by PKC activity raised by increased glucose in ratdepletion in glutathione may contribute to an increase
in the intracellular levels of H2O2 [7, 8] or most recently aortic smooth muscle cells overexpressing PKCd [47].
However, PKCd is not altered in the glomerulus in diabe-in H2O2-treated cultured neonatal ventricular myocytes
[11]. Additionally, a protection against tumor necrosis tes [45], although increased PKCd immunofluorescence,
distributed in a cytoskeletal pattern, is seen in mesangialfactor-a (TNF-a)–induced cytotoxicity, seen in Hsp-27-
transfected cells, required that Hsp27 be maintained in cells exposed to raised glucose in the short term in which
F-actin assembly/disassembly is found [33]. In this study,the large oligomeric state. In this latter condition, there
is a reduction in reactive oxygen species and an increase beyond the demonstration of p38MAPK activation, the
effect of raised glucose levels has not been investigatedin cellular glutathione content [8]. These authors have
proposed that this may be due to the ability of large further. Rather, the direct effects of an oxidative stress
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have been considered. It would appear that a reduction chaperone functions [55]. There is currently considerable
interest in the expression and tissue localization of smallin Hsp25 molecular aggregate size, H2O2-induced small
Hsp phosphorylation, and H2O2-induced loss in mesan- Hsps in experimental renal perturbations with direct rel-
evance to human disease [28–30] and in human diseasegial cell contractile responsiveness is effected by a
p38MAPK-dependent pathway rather than a PKC- states, including increased localization to tumor micro-
vascular endothelial proliferations and blood vessels [56]dependent pathway, at least as indicated by the
p38MAPK inhibitor SB202190. SB202190 is widely re- and alterations to cardiac tissue that occur in the diseased
heart [57]. Although not considered previously, thesegarded as a highly effective inhibitor of p38MAPK, and
although some lack of exclusivity among the stress- aspects and their implications should now be considered
in the renal glomerulus in diabetes.related kinases should be considered [48], PKC activa-
tion is not inhibited by SB202190 [49].
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